PRIONRX SCIENCE
Live / Registered — Registered (as of 20 Sept 2022)
What this means for you
Registered since 20 Sept 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 20 Sept 2028: the §8 declaration of use).
Record
- Serial number
- 90552063
- Registration number
- 6853528
- Mark type
- Word mark
- Filed
- 01 Mar 2021
- Published for opposition
- 16 Nov 2021
- Registered
- 20 Sept 2022
- Next maintenance filing
- §8 declaration of use, due by 20 Sept 2028 (grace period to 20 Mar 2029)
- Attorney of record
- Benjamen E. Kern
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug development services
Owner
- Amprion, Inc., San Francisco, CA, US
- Amprion, Inc., San Francisco, CA, US
- Amprion, Inc., San Francisco, CA, US
Prosecution history
- 20 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 19 Aug 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Aug 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Aug 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Jul 2022 — USE AMENDMENT FILED
- 09 Aug 2022 — SOU EXTENSION 1 GRANTED
- 11 Jul 2022 — SOU EXTENSION 1 FILED
- 06 Aug 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Jul 2022 — NOTICE OF REVIVAL - E-MAILED
- 13 Jul 2022 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 13 Jul 2022 — PETITION TO REVIVE-GRANTED
- 13 Jul 2022 — TEAS PETITION TO REVIVE RECEIVED
- 13 Jul 2022 — TEAS STATEMENT OF USE RECEIVED